Veracyte | VCYT - Operating Expenses

Stock Price
35.80
Daily Change
-1.94 -5.14%
Monthly
-17.95%
Yearly
-20.80%
Q1 Forecast
36.91

Veracyte reported $108.76M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Agilent USD 1.42B 57M Sep/2025
Arrowhead Research USD 212.37M 19.05M Sep/2025
Bruker USD 776.6M 8.9M Sep/2025
Exact Sciences USD 875.74M 62.51M Sep/2025
Illumina USD 834M 20M Sep/2025
Laboratory Of America USD 3.17B 101.7M Sep/2025
Ligand Pharmaceuticals USD 8.29M 32.17M Sep/2025
Myriad Genetics USD 229M 3.4M Sep/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Siemens EUR 18.86B 2.24B Sep/2025
Sonic Healthcare AUD 4.23B 2.14B Dec/2024
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Veracyte USD 108.76M 7.09M Sep/2025
Waters USD 2.33B 1.75B Sep/2025